While VEGF-C overexpression in immune competent hosts remained pro-metastatic, it became further evident that tumor-associated lymphangiogenesis boosted fluid and DC transport to lymph nodes and intratumoral inflammation [64] leading to the hypothesis that lymphatic transport was not only necessary for immune surveillance but could be boosted for therapeutic benefit. This evidence concerns the gene VEGFC and neoplasm.